Allocations of Johnson & Johnson's coronavirus vaccine will plummet by 80% next week, according to data released by the Centers for Disease and Control Prevention.
Why it matters: J&J's single-dose shot is viewed as key to U.S. efforts to vaccinate enough Americans to reach herd immunity as soon as possible. A spokesperson told the Wall Street Journal that J&J is still aiming to meet its goal of delivering 100 million doses by June.
